search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MICROBIOLOGY


Shiga toxin-producing Escherichia coli (STEC): a diagnostic conundrum


Following on from his recent article on Escherichia coli, Dr Neil Bentley looks at Shiga toxin-producing E. coli (STEC), considering the multiple challenges posed by this pathogen and recent diagnostic advances.


Shiga toxin-producing Escherichia coli (STEC) represents one of the most critical foodborne pathogens worldwide. Responsible for a clinical spectrum ranging from self-limited diarrhoea to life- threatening systemic complications such as haemolytic uraemic syndrome (HUS). STEC infections arise from a complex interaction between bacterial virulence, host susceptibility, and environmental factors. Notably, STEC has an extremely low infectious dose, with less than 100 bacteria capable of eliciting severe disease.1


In an era of globalisation that


interconnects food supply chains, coupled with climate change which reshapes pathogen ecology; our understanding and mitigation of STEC risks must be both multifaceted and dynamic. Here, we review the historical evolution and scientific advances in STEC research, including transmission dynamics, molecular pathogenicity, diagnostic challenges, and the broader socio- economic and public health implications of STEC outbreaks.


Historical overview of STEC


n Discovery of Escherichia coli and early observations


In 1885, Theodor Escherich isolated E. coli from neonatal intestinal tracts, establishing its status as a commensal inhabitant of the gastrointestinal system.2 Over time, scientists identified that while


most E. coli strains are commensals, a subset could cause disease. An example is the identification of enteropathogenic E. coli (EPEC) in the 1940s, which identified that certain strains were able to cause diarrhoea and dysentery,3


the underlying pathogenic potential of some E. coli pathotypes.


n Discovery of Shiga toxin The groundbreaking work of Kiyoshi Shiga between 1897 and 1898 led to the identification of Shigella dysenteriae and its potent toxin responsible for causing severe dysentery.4


the discovery that certain E. coli strains produced toxins immunologically and functionally analogous to Shiga toxin gave rise to the classification of STEC.5


n STEC emerges as a major foodborne pathogen


indicating


By the early 1980s, scientists began to systematically screen E. coli strains for toxin production, leading to the identification of STEC strains that produced Shiga toxins. This distinction


Subsequently,


A three-dimensional illustration of Escherichia coli bacteria. WWW.PATHOLOGYINPRACTICE.COM APRIL 2025 39


AdobeStock / PRB ARTS


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56